FGK Clinical Research

Munich, Germany· Est. 1990

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

FGK Clinical Research is a well-established, mid-sized, private CRO headquartered in Munich, Germany, with over 230 employees. It operates as a full-service provider across a wide range of therapeutic areas, with particular expertise in Medical Devices and Advanced Therapy Medicinal Products (ATMPs). The company's strategy is centered on close, owner-driven partnerships with small to mid-sized sponsors, offering flexibility and deep operational experience across Europe, as evidenced by its recent expansion into the Netherlands.

Medical DevicesAdvanced Therapy Medicinal Product (ATMP)OncologyNeurologyPsychiatryDentistryCardiovascularInfectionsOphthalmologyPneumologyGastroenterologyGynecologyUrologyEndocrine / Metabolic DisordersDermatologyRare Diseases

Technology Platform

Integrated full-service CRO model with a tailored-service approach. Emphasizes close integration of project management and monitoring, with project managers maintaining site-level oversight. Expertise in complex regulatory areas (Medical Devices, ATMPs). Utilizes standard clinical trial technologies (eCRF, study-specific plans).

Opportunities

Growing demand from small-to-mid-sized biotech/pharma companies outsourcing complex clinical development.

Increasing complexity in specialized fields like ATMPs and medical devices creates need for niche expertise.

European regulatory harmonization (CTR) and strategic geographic expansion (e.g., into the Netherlands) present avenues for growth.

Risk Factors

High competition from large, global CROs with greater resources.

Revenue dependency on the R&D spending cycles of client sponsors, which can be volatile.

Operational risks associated with trial execution, including regulatory compliance failures or data issues, especially in complex therapy areas.

Competitive Landscape

Operates in the highly competitive global CRO market, competing against large players like IQVIA, Parexel, and PPD. Differentiates itself as a mid-sized, owner-driven, and flexible service provider targeting small-to-mid-sized sponsors. Competes with other regional and specialist CROs on the basis of deep therapeutic expertise, particularly in Medical Devices and ATMPs.